2m 2m 2m 2m 2m 2m 2m
LABCORP HLDGS (LH)
NYSE
$257.55+$3.12 (+1.23%)
Price as of Jun 23, 2026 7:59 PM EDT- $20.9BMarket Cap
- -1.50%1-Year Change
- Diagnostics & ResearchIndustry
LABCORP HLDGS (LH)
$257.55+$3.12 (+1.23%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 14.0B +7.25% | 13.0B +6.97% | 12.2B -18.25% | 14.9B -7.72% | |
Cost of Revenue | 9.9B +5.91% | 9.4B +6.68% | 8.8B -16.16% | 10.5B -0.05% | |
Gross Profit | 4.0B +10.71% | 3.6B +7.71% | 3.4B -23.27% | 4.4B -22.03% | |
Sales and Marketing Expense | 2.2B -0.61% | 2.2B +10.32% | 2.0B +1.24% | 2.0B +2.28% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 681.1M +5.84% | 643.5M +11.47% | 577.3M -8.93% | 633.9M -14.92% | |
Total Operating Expenses | 2.2B -0.61% | 2.2B +10.32% | 2.0B +1.24% | 2.0B +2.28% | |
Operating Profit | 1.4B +27.42% | 1.1B +49.77% | 725.6M -59.10% | 1.8B -45.58% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -224.1M +7.59% | -208.3M +4.36% | -199.6M +10.70% | -180.3M -14.99% | |
Interest Income and Expense and Net | -224.1M +7.59% | -208.3M +4.36% | -199.6M +10.70% | -180.3M -14.99% | |
Total Nonoperating Income and Expense | -55.0M -191.36% | 60.2M +288.39% | 15.5M +161.26% | -25.3M -159.53% | |
Income before Taxes | 877.7M +17.48% | 747.1M +96.40% | 380.4M -78.56% | 1.8B -45.58% | |
Income Taxes | 229.8M +8.19% | 212.4M +12.68% | 188.5M -37.58% | 302.0M -59.58% | |
Extraordinary Items | 4.3M -18.87% | 5.3M N/A | N/A N/A | N/A N/A | |
Net Income | 876.5M +17.49% | 746.0M +78.47% | 418.0M -67.32% | 1.3B -46.20% | |
Net Income from Continuing Operations Applicable to Common | 877.7M +17.48% | 747.1M +96.40% | 380.4M -70.26% | 1.3B -46.20% | |
Basic EPS and Net Income | 10.54 +18.56% | 8.89 +85.21% | 4.80 -65.84% | 14.05 -42.89% | |
Diluted EPS and Net Income | 10.46 +18.33% | 8.84 +85.32% | 4.77 -65.86% | 13.97 -42.72% | |
Basic Weighted Average Shares | 83.2M -0.83% | 83.9M -3.67% | 87.1M -4.39% | 91.1M -5.79% | |
Diluted Weighted Average Shares | 83.8M -0.71% | 84.4M -3.65% | 87.6M -4.37% | 91.6M -6.05% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 532.3M -64.95% | 1.5B +182.92% | 536.8M +24.84% | 430.0M -70.80% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 532.3M -64.95% | 1.5B +182.92% | 536.8M +24.84% | 430.0M -70.80% | |
Total Current Assets | 4.0B -16.35% | 4.8B +27.65% | 3.8B -18.59% | 4.6B -13.24% | |
Accumulated Depreciation | 3.3B +6.48% | 3.1B +5.71% | 2.9B +6.70% | 2.7B +12.83% | |
Property and Plant and Equipment and Net | 3.1B +1.19% | 3.0B +4.59% | 2.9B -1.50% | 3.0B +5.00% | |
Total Long-Term Assets | 751.3M +15.19% | 652.2M +21.57% | 536.5M +23.99% | 432.7M -6.46% | |
Total Assets | 18.4B +0.07% | 18.4B +9.89% | 16.7B -17.02% | 20.2B -1.13% | |
Income Taxes Payable | 160.3M +4.98% | 152.7M +19.76% | 127.5M -12.73% | 146.1M -39.02% | |
Total Short-Term Debt | 500.1M -50.02% | 1.0B -0.02% | 1.0B +230.33% | 303.0M +10,000.00% | |
Total Current Liabilities | 2.8B -15.22% | 3.3B +3.26% | 3.2B +4.77% | 3.1B +10.62% | |
Total Long-Term Debt | 5.1B -4.63% | 5.3B +31.48% | 4.1B -19.53% | 5.0B -6.97% | |
Total Long-Term Liabilities | 647.8M +25.20% | 517.4M +26.41% | 409.3M -3.19% | 422.8M +5.17% | |
Total Liabilities | 9.8B -5.40% | 10.3B +16.73% | 8.8B -12.00% | 10.0B -0.51% | |
Retained Earnings | 8.6B +4.05% | 8.3B +5.26% | 7.9B -25.45% | 10.6B +1.19% | |
Total Stockholders Equity | 8.6B +7.05% | 8.1B +2.25% | 7.9B -22.00% | 10.1B -1.72% | |
Total Shares Outstanding | 82.2M -1.44% | 83.4M -0.60% | 83.9M -4.88% | 88.2M -5.26% | |
Cash Flow | |||||
Cash from Operating Activities | 1.6B +3.45% | 1.6B +19.44% | 1.3B -32.12% | 2.0B -37.10% | |
Capital Expenditures | 434.5M -11.31% | 489.9M +8.00% | 453.6M -5.87% | 481.9M +4.67% | |
Cash from Investing Activities | -1.2B -12.64% | -1.4B +16.67% | -1.2B -29.09% | -1.7B +86.77% | |
Dividends Paid | 240.7M -0.99% | 243.1M -4.29% | 254.0M +30.12% | 195.2M N/A | |
Cash from Financing Activities | -1.5B -286.82% | 779.9M +1,415.18% | -59.3M -95.52% | -1.3B -36.00% | |
Financials Ratio | |||||
Gross Margin | 28.76% +3.23% | 27.86% +0.70% | 27.67% -6.13% | 29.48% -15.51% | |
Operating Margin | 9.93% +18.81% | 8.35% +40.01% | 5.97% -49.96% | 11.92% -41.03% | |
Return on Assets | 4.77% +12.17% | 4.25% +87.50% | 2.27% -64.08% | 6.31% -46.31% | |
Return on Equity | 10.51% +12.24% | 9.37% +101.38% | 4.65% -62.96% | 12.56% -48.14% | |
Revenue Growth | 7.25% +4.02% | 6.97% +138.17% | -18.25% +136.50% | -7.72% -150.35% | |
Current Ratio | 1.42 -1.34% | 1.44 +23.62% | 1.17 -22.29% | 1.50 -21.56% | |
Cash Ratio | 0.19 -58.66% | 0.46 +174.04% | 0.17 +19.11% | 0.14 -73.60% | |
Debt-to-Equity Ratio | 0.65 -17.61% | 0.79 +22.49% | 0.64 +21.34% | 0.53 +0.30% | |
Debt-to-Assets Ratio | 0.30 -11.87% | 0.34 +13.96% | 0.30 +14.08% | 0.27 -0.34% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow